| Title | Date | Affymetrix to Webcast Annual Meeting of Shareholders| SANTA CLARA, Calif.--(BUSINESS WIRE)--Jun. 11, 2009--
Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast its
Annual Meeting of Shareholders live at 4 p.m. (PT), on June 17, 2009.
Following the formal business of the meeting, Affymetrix President and
Chief Executive Officer Kevin King will provide an update on the company
and its accomplishments in fiscal year 2008.
A live webcast of the presentation will be available at http:... |
| 06/11/09 | Key Milestones to Improve Operating Leverage Achieved Ahead of Schedule| New Array Center Will Benefit Affymetrix Investors and Customers
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jun. 2, 2009--
Affymetrix, Inc. (Nasdaq:AFFX) today announced the
earlier-than-anticipated achievement of two key milestones in its plan
to consolidate array manufacturing, set a new standard in reagent
capabilities, and relocate US product distribution. That plan is part of
a broader three-part strategic initiative to return Affymetrix to growth
a... |
| 06/02/09 | Affymetrix Chief Medical Officer to speak at AAAS on Personalized Medicine| SANTA CLARA, Calif.--(BUSINESS WIRE)--May. 29, 2009--
Affymetrix, Inc., (Nasdaq: AFFX) today announced that its Chief Medical
Officer, Dr. Rick Hockett, will address the topic of ‘Personalized
Medicine: Planning for the Future’ at a meeting of the American
Association for the Advancement of Science (AAAS) and the Food and Drug
Law Institute (FDLI) on June 1 in Washington, DC.
Dr. Hockett will speak in a panel discussion at 10:15 AM Eastern ti... |
| 05/29/09 | Entrepreneur Magazine Picks Affymetrix as One of Top 100 Companies to Watch| SANTA CLARA, Calif.--(BUSINESS WIRE)--May. 28, 2009--
Affymetrix, Inc., (Nasdaq:AFFX) today announced that it has been
selected by Entrepreneur magazine as one of the top 100 companies
to watch. Affymetrix was listed under health care, which the magazine
describes as one of the ten hottest industry categories right now. Entrepreneur
has been published for 30 years, covering the diverse challenges of
business ownership.
Commenting in it... |
| 05/28/09 | Affymetrix to Webcast Investor Day 2009| SANTA CLARA, Calif.--(BUSINESS WIRE)--May. 20, 2009--
Affymetrix Inc., (Nasdaq:AFFX) today announced that it will webcast the
company’s Investor Day 2009 conference the morning of Wednesday, June 3,
2009. The event will be held at the Nasdaq MarketSite in New York City,
starting at 10:00 a.m. (EDT).
The meeting will feature presentations by members of the senior
management team including Kevin King (CEO), John Batty (CFO) and Jay
Kaufm... |
| 05/20/09 | Affymetrix Appoints Gary Guthart to Board of Directors| SANTA CLARA, Calif.--(BUSINESS WIRE)--May. 11, 2009--
Affymetrix Inc., (Nasdaq:AFFX) announced today that Gary S. Guthart,
Ph.D., President and Chief Operating Officer of Intuitive Surgical, has
been elected to the company’s board of directors.
“We are pleased to add Gary Guthart to the company’s board,” said Steve
P.A. Fodor, Ph.D., founder and executive chairman of Affymetrix. “His
track record of operational strength, strategic vision and ... |
| 05/11/09 | Affymetrix to Webcast Presentations at May Financial Conferences| SANTA CLARA, Calif.--(BUSINESS WIRE)--May. 5, 2009--
Affymetrix, Inc. (Nasdaq:AFFX) today announced that company management
will provide a corporate overview at two financial conferences in May.
John Batty, Executive Vice President and CFO, will present at the
following conferences:
Bank of America and Merrill Lynch 2009 Health Care conference in NYC
on May 13, 2009 at 3:20p ET
Deutsche Bank Health... |
| 05/05/09 | Affymetrix Chosen as One of the Top Places to Work in the Bay Area| Employees Give High Marks for Their Co-Workers in San Francisco Business Times Competition
SANTA CLARA, Calif.--(BUSINESS WIRE)--Apr. 30, 2009--
Affymetrix, Inc. (Nasdaq: AFFX) today was named “One of the Best Places
to Work in the Bay Area” by the the San Francisco Business Times.
This year's list recognizes Bay Area companies for their employee
engagement, as measured by an independent survey of nearly 400 area
businesses. Employees were asked to rate th... |
| 04/30/09 | Affymetrix Reports First Quarter 2009 Results| SANTA CLARA, Calif.--(BUSINESS WIRE)--Apr. 22, 2009--
Affymetrix Inc., (NASDAQ:AFFX) today reported its operating results for
the first quarter of 2009. Total revenue for the quarter was $78.6
million, as compared to total revenue of $169.6 million, including an
intellectual property payment of $90 million, in the first quarter of
2008.
Product revenue was $64.9 million, which consisted of consumable (array
and reagent) revenue of $59.... |
| 04/22/09 | Six New Genes Associated with Heart Attacks| Affymetrix(R) Microarray Technologies Help Scientists Understand the Genetic Risk of Heart Attacks
SANTA CLARA, Calif.--(BUSINESS WIRE)--Apr. 22, 2009--
Affymetrix, Inc. (Nasdaq:AFFX) today announced that its GeneChip®
genotyping technology played a part in the recently announced
discoveries of six new genes associated with susceptibility to heart
attacks. Scientists from the University of Lübeck, Germany, and
Massachusetts General Hospital, USA together w... |
| 04/22/09 | Affymetrix to Host Conference Call on April 22, 2009 to Announce First Quarter 2009 Results| SANTA CLARA, Calif., Apr 14, 2009 (BUSINESS WIRE) -- Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will release
operating results for the first quarter of 2009 after close of the stock
market on Wednesday, April 22, 2009.
Affymetrix' management team will host a conference call on April 22,
2009 at 2:00 PM PT to review its operating results for the first quarter
2009. A live webcast can be accessed by visiting the Investor Relations
section of the... |
| 04/14/09 | New Cytogenetics Products Offer Best Overall Approach for Detection of Chromosome Aberrations| Comprehensive, microarray-based analysis designed specifically for cytogeneticists
SANTA CLARA, Calif., March 25, 2009 – Today, Affymetrix, Inc. (Nasdaq: AFFX) launched its next-generation series of products for cytogenetics. The entirely new Affymetrix® Cytogenetics Research Solution, which includes arrays, reagents, and software, enables fast and reliable detection of known and novel chromosome aberrations.
“We worked closely with the cytogenetics community to develop these products,” sa... |
| 03/25/09 | Affymetrix and Genisphere Launch Best-in-Class Solution for microRNA Expression Research| Benefits Include Fastest Labeling Assay on the Market and Industry-Leading Array Content Covering 71 Organisms
SANTA CLARA, Calif.--(BUSINESS WIRE)--Mar. 16, 2009--
Affymetrix, Inc. (Nasdaq:AFFX) and Genisphere Inc. today announced the
launch of a new, best-in-class solution for microRNA (miRNA) research
studies. Encompassing assay, array, and software, the solution offers
comprehensive miRNA coverage for 71 organisms on a single array. Covered
species inc... |
| 03/16/09 | Affymetrix to Webcast Presentations at Two March Financial Conferences| SANTA CLARA, Calif., Mar 04, 2009 (BUSINESS WIRE) -- Affymetrix, Inc. (NASDAQ:AFFX) today announced that company management
will provide a corporate overview at two upcoming financial conferences.
John Batty, Executive Vice President and CFO, will present at the
Barclays Capital Global Healthcare Conference in Miami. A live
transmission of the presentation will take place at 3:15 P.M. ET on
Wednesday, March 11, 2009. An archived webcast will be available for 30
... |
| 03/04/09 | Affymetrix Reports Fourth Quarter and Fiscal Year 2008 Results| Fourth Quarter Includes Approximately $253 Million of Goodwill Impairment and Restructuring Charges
SANTA CLARA, Calif.--(BUSINESS WIRE)--
Affymetrix Inc., (NASDAQ:AFFX) today reported its operating results for
the fourth quarter and fiscal year ended December 31, 2008. Total
revenue for the fourth quarter was $78.6 million, as compared to total
revenue of $107.6 million in the fourth quarter of 2007. For the full
year, total revenue was $410.2 million as ... |
| 01/28/09 |
|
